Comparison of three clinical rating scales in Friedreich ataxia (FRDA)

To test the validity and reliability of the scale for the assessment and rating of ataxia (SARA) in Friedreich ataxia (FRDA). SARA is limited to eight items and can be performed rapidly. Ninety‐six patients with a molecular genetic diagnosis of FRDA were rated using three different clinical scales, the FRDA Rating Scale (FARS), the International Cooperative Ataxia Rating Scale (ICARS), and SARA. Despite considerable discrepancies in scale size and subscale structure, SARA total scores were significantly correlated with ICARS (r = 0.953, P < 0.0001) and FARS (r = 0.938, P < 0.0001) total scores. SARA total scores also correlated with the activities of daily living (ADL, r = 0.929, P < 0.0001). Although originally developed for the use in dominantly inherited ataxias, which are primarily ataxias of the cerebellar type, SARA can also be used successfully to assess afferent ataxia, which is the predominant form in FRDA. Because SARA is characterized by high interrater reliability and practicability, SARA is applicable and well suited forclinical trials of FRDA. © 2009 Movement Disorder Society

[1]  Elsdon Storey,et al.  Inter‐rater reliability of the International Cooperative Ataxia Rating Scale (ICARS) , 2004, Movement disorders : official journal of the Movement Disorder Society.

[2]  W. Poewe,et al.  Application of the International Cooperative Ataxia Scale rating in multiple system atrophy , 2002, Movement disorders : official journal of the Movement Disorder Society.

[3]  J. Hobart,et al.  International cooperative ataxia rating scale (ICARS): Appropriate for studies of Friedreich's ataxia? , 2005, Movement disorders : official journal of the Movement Disorder Society.

[4]  Xiao-Li Meng,et al.  Comparing correlated correlation coefficients , 1992 .

[5]  L. Corben,et al.  How is disease progress in Friedreich’s ataxia best measured? A study of four rating scales , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  M. Hallett,et al.  International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome , 1997, Journal of the Neurological Sciences.

[7]  Lippincott Williams Wilkins,et al.  Scale for the assessment and rating of ataxia: Development of a new clinical scale , 2006, Neurology.

[8]  S. Rivaud-Pechoux,et al.  Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up. , 2007, Archives of neurology.

[9]  Paola Giunti,et al.  Reliability and validity of the International Cooperative Ataxia Rating Scale: A study in 156 spinocerebellar ataxia patients , 2006, Movement disorders : official journal of the Movement Disorder Society.

[10]  A. Harding.  Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. , 1981, Brain : a journal of neurology.

[11]  M. Hallett,et al.  Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale , 2005, Neurology.

[12]  R. Artuch,et al.  Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up. , 2008, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[13]  Markus Frings,et al.  Reliability and validity of ICARS in focal cerebellar lesions , 2007, Movement disorders : official journal of the Movement Disorder Society.

[14]  W. Poewe,et al.  Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin , 2007, Annals of neurology.

[15]  Markus Frings,et al.  Reliability and validity of the scale for the assessment and rating of ataxia: A study in 64 ataxia patients , 2007, Movement disorders : official journal of the Movement Disorder Society.